Search

Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

643 results found

Article

Quarles & Brady LLP | USA | 16 Apr 2020

DEA Temporarily Removes the ‘Five Percent Rule’

Through an April 13, 2020 letter to registered practitioners, the Drug Enforcement Administration (DEA) announced that, effective January 1, 2020…
Article

FisherBroyles LLP | USA | 15 Apr 2020

DEA Issues Exception to “Five Percent Rule” in Response to COVID-19

Since Secretary of Health and Human Services Alex Azar declared a public health emergency in response to COVID-19 on January 31, 2020, the Drug…
Article

Quarles & Brady LLP | USA | 9 Apr 2020

DEA Issues Final Order Increasing APQs for Certain Controlled Substances

On April 7, 2020, the Drug Enforcement Administration (DEA) issued a Final Order that increased aggregate production quotas (APQ) for certain…
Article

Thompson Hine LLP | USA | 31 Mar 2020

Emergency Orders Increase Access to Medical Care and Reimbursement for Telehealth Services During COVID-19 Public Health Emergency

In response to the need to limit the spread of COVID-19, federal and Ohio state agencies have lifted restrictions on the practice of telehealth…
Article

Bass, Berry & Sims PLC | USA | 27 Mar 2020

Expanding Accessibility of Telehealth Services During the COVID-19 Pandemic

In light of community spread of COVID-19, federal and state regulators continue to take action to promote the expanded use of telehealth to reach…
Article

Quarles & Brady LLP | USA | 5 Mar 2020

Key Takeaways of the DEA’s 2019 National Drug Threat Assessment

The US Drug Enforcement Administration (DEA) recently released its annual National Drug Threat Assessment. While highlighting challenges with illicit…
Article

Michael Best & Friedrich LLP | USA | 27 Feb 2020

USDA and DEA Relax Lab Requirements for Hemp Testing

In a significant shift for the 2020 hemp crop year, the U.S. Department of Agriculture (USDA) and Drug Enforcement Administration (DEA) reached an…
Article

Ropes & Gray LLP | USA | 4 Feb 2020

2019 FDA Enforcement Review: Drugs, Biologics, Devices, and Dietary Supplements

The ongoing public health crises of opioid addiction and youth vaping1 undoubtedly captured Significant attention and enforcement resources in 2019, a…
Article

Kramer Levin Naftalis & Frankel LLP | USA | 28 Jan 2020

Delaware Chancery Court Holds That Stockholders Had a “Proper Purpose” to Seek Board Materials From Opioid Distributor, and Orders a 30(b)(6) Deposition, in Section 220 Books and Records Action

In a 63-page decision issued on Jan. 13, 2020, in Lebanon County Employees’ Retirement Fund v. AmerisourceBergen Corporation, Vice Chancellor…
Article

Kelley Drye & Warren LLP | USA | 22 Jan 2020

House Subcommittee Holds Hearing on Current Cannabis Policies

On January 15, the Subcommittee on Health of the Committee on Energy and Commerce held its first ever legislative hearing to address federal cannabis…
Previous page 1 2 3 ...